Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8187083rdf:typepubmed:Citationlld:pubmed
pubmed-article:8187083lifeskim:mentionsumls-concept:C0015576lld:lifeskim
pubmed-article:8187083lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:8187083lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:8187083lifeskim:mentionsumls-concept:C0037993lld:lifeskim
pubmed-article:8187083lifeskim:mentionsumls-concept:C0033684lld:lifeskim
pubmed-article:8187083lifeskim:mentionsumls-concept:C1705630lld:lifeskim
pubmed-article:8187083lifeskim:mentionsumls-concept:C1515926lld:lifeskim
pubmed-article:8187083pubmed:issue11lld:pubmed
pubmed-article:8187083pubmed:dateCreated1994-6-21lld:pubmed
pubmed-article:8187083pubmed:abstractTextIt has recently been shown that T-cell signal transduction molecules are altered in tumor-bearing mice. We have examined the expression of NF kappa B/Rel family proteins in T-cells from mice bearing Renca, a murine renal carcinoma. T-cells from Renca-bearing mice expressed undetectable levels of nuclear c-Rel, NF kappa B p65, and p50; however, two shorter forms of p50 (p48 and p46), truncated at the NH2-terminus, were present exclusively in the nucleus and were able to bind DNA. These T-cells have reduced expression of gamma-interferon mRNA. In mice successfully treated with flavone 8-acetic acid and recombinant human interleukin 2, the T-cells expressed normal levels of all three nuclear NF kappa B/Rel proteins. These results suggest that alterations in transcription factors may accompany changes in signal transduction molecules in T-cells from tumor-bearing animals; however, the changes are reversed with successful biological therapy.lld:pubmed
pubmed-article:8187083pubmed:languageenglld:pubmed
pubmed-article:8187083pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8187083pubmed:citationSubsetIMlld:pubmed
pubmed-article:8187083pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8187083pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8187083pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8187083pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8187083pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8187083pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8187083pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8187083pubmed:statusMEDLINElld:pubmed
pubmed-article:8187083pubmed:monthJunlld:pubmed
pubmed-article:8187083pubmed:issn0008-5472lld:pubmed
pubmed-article:8187083pubmed:authorpubmed-author:GhoseSSlld:pubmed
pubmed-article:8187083pubmed:authorpubmed-author:LongoD LDLlld:pubmed
pubmed-article:8187083pubmed:authorpubmed-author:YoungH AHAlld:pubmed
pubmed-article:8187083pubmed:authorpubmed-author:RichN WNWlld:pubmed
pubmed-article:8187083pubmed:authorpubmed-author:WiltroutR HRHlld:pubmed
pubmed-article:8187083pubmed:authorpubmed-author:SickKKlld:pubmed
pubmed-article:8187083pubmed:authorpubmed-author:YuZZlld:pubmed
pubmed-article:8187083pubmed:authorpubmed-author:KomschliesK...lld:pubmed
pubmed-article:8187083pubmed:authorpubmed-author:FrancoJ LJLlld:pubmed
pubmed-article:8187083pubmed:issnTypePrintlld:pubmed
pubmed-article:8187083pubmed:day1lld:pubmed
pubmed-article:8187083pubmed:volume54lld:pubmed
pubmed-article:8187083pubmed:ownerNLMlld:pubmed
pubmed-article:8187083pubmed:authorsCompleteYlld:pubmed
pubmed-article:8187083pubmed:pagination2969-72lld:pubmed
pubmed-article:8187083pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:8187083pubmed:meshHeadingpubmed-meshheading:8187083-...lld:pubmed
pubmed-article:8187083pubmed:meshHeadingpubmed-meshheading:8187083-...lld:pubmed
pubmed-article:8187083pubmed:meshHeadingpubmed-meshheading:8187083-...lld:pubmed
pubmed-article:8187083pubmed:meshHeadingpubmed-meshheading:8187083-...lld:pubmed
pubmed-article:8187083pubmed:meshHeadingpubmed-meshheading:8187083-...lld:pubmed
pubmed-article:8187083pubmed:meshHeadingpubmed-meshheading:8187083-...lld:pubmed
pubmed-article:8187083pubmed:meshHeadingpubmed-meshheading:8187083-...lld:pubmed
pubmed-article:8187083pubmed:meshHeadingpubmed-meshheading:8187083-...lld:pubmed
pubmed-article:8187083pubmed:meshHeadingpubmed-meshheading:8187083-...lld:pubmed
pubmed-article:8187083pubmed:meshHeadingpubmed-meshheading:8187083-...lld:pubmed
pubmed-article:8187083pubmed:meshHeadingpubmed-meshheading:8187083-...lld:pubmed
pubmed-article:8187083pubmed:meshHeadingpubmed-meshheading:8187083-...lld:pubmed
pubmed-article:8187083pubmed:meshHeadingpubmed-meshheading:8187083-...lld:pubmed
pubmed-article:8187083pubmed:meshHeadingpubmed-meshheading:8187083-...lld:pubmed
pubmed-article:8187083pubmed:meshHeadingpubmed-meshheading:8187083-...lld:pubmed
pubmed-article:8187083pubmed:meshHeadingpubmed-meshheading:8187083-...lld:pubmed
pubmed-article:8187083pubmed:meshHeadingpubmed-meshheading:8187083-...lld:pubmed
pubmed-article:8187083pubmed:meshHeadingpubmed-meshheading:8187083-...lld:pubmed
pubmed-article:8187083pubmed:year1994lld:pubmed
pubmed-article:8187083pubmed:articleTitleAlterations in NF kappa B/Rel family proteins in splenic T-cells from tumor-bearing mice and reversal following therapy.lld:pubmed
pubmed-article:8187083pubmed:affiliationLaboratory of Experimental Immunology, NCI-FCRDC, Frederick, Maryland 21702-1201.lld:pubmed
pubmed-article:8187083pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8187083lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8187083lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8187083lld:pubmed